A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris

Status:
Completed

Trial end date:
2016-04-01

Target enrollment:

Participant gender:

The objectives of this study are to assess the safety and efficacy DRM01 Topical Gel compared to vehicle in patients with acne vulgaris.

Phase 2

Dermira, Inc.